User profiles for "author:J Poole"
Jason PooleVP, Research and Development at Biocept Inc. Verified email at biocept.com Cited by 2828 |
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
campaigns have helped to raise awareness about the impact of cardiovascular disease in …
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) expert consensus statement on the perioperative management of patients with …
GH Crossley, JE Poole, MA Rozner… - Heart …, 2011 - heartrhythmjournal.com
The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert
Consensus Statement on the Perioperative Management of Patients with Implantable …
Consensus Statement on the Perioperative Management of Patients with Implantable …
Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT)
JC Poole, LG Andrews, TO Tollefsbol - Gene, 2001 - Elsevier
Recent interest in the regulation of telomerase, the enzyme that maintains chromosomal
termini, has lead to the discovery and characterization of the catalytic subunit of telomerase …
termini, has lead to the discovery and characterization of the catalytic subunit of telomerase …
[HTML][HTML] Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure
GH Bardy, KL Lee, DB Mark, JE Poole… - … England Journal of …, 2005 - Mass Medical Soc
Background Sudden death from cardiac causes remains a leading cause of death among
patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable …
patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable …
[HTML][HTML] Prognostic importance of defibrillator shocks in patients with heart failure
JE Poole, GW Johnson, AS Hellkamp… - … England Journal of …, 2008 - Mass Medical Soc
Background Patients with heart failure who receive an implantable cardioverter–defibrillator
(ICD) for primary prevention (ie, prevention of a first life-threatening arrhythmic event) may …
(ICD) for primary prevention (ie, prevention of a first life-threatening arrhythmic event) may …
Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA …
DL Packer, DB Mark, RA Robb, KH Monahan… - Jama, 2019 - jamanetwork.com
Importance Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF),
but its effects on long-term mortality and stroke risk are uncertain. Objective To determine …
but its effects on long-term mortality and stroke risk are uncertain. Objective To determine …
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE …
JE Poole, MJ Gleva, T Mela, MK Chung, DZ Uslan… - Circulation, 2010 - Am Heart Assoc
Background—Prospective studies defining the risk associated with pacemaker or
implantable cardioverter-defibrillator replacement surgeries do not exist. These procedures …
implantable cardioverter-defibrillator replacement surgeries do not exist. These procedures …
[PDF][PDF] CONSENSUS DOCUMENT
…, H Burri, JC Nielsen, MG Bongiorni, J Poole… - European Heart …, 2020 - rythmolyon.fr
Pacemakers, implantable cardiac defibrillators (ICDs), and cardiac resynchronization
therapy (CRT) devices are lifesaving treatments for a number of cardiac conditions. Device …
therapy (CRT) devices are lifesaving treatments for a number of cardiac conditions. Device …
An enhanced MITOMAP with a global mtDNA mutational phylogeny
E Ruiz-Pesini, MT Lott, V Procaccio… - Nucleic acids …, 2007 - academic.oup.com
The MITOMAP () data system for the human mitochondrial genome has been greatly
enhanced by the addition of a navigable mutational mitochondrial DNA (mtDNA) …
enhanced by the addition of a navigable mutational mitochondrial DNA (mtDNA) …
Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial
DB Mark, KJ Anstrom, S Sheng, JP Piccini, KN Baloch… - Jama, 2019 - jamanetwork.com
Importance Catheter ablation is more effective than drug therapy in restoring sinus rhythm in
patients with atrial fibrillation (AF), but its incremental effect on long-term quality of life (QOL) …
patients with atrial fibrillation (AF), but its incremental effect on long-term quality of life (QOL) …